Anavex Historical Income Statement
| AVXL Stock | USD 9.11 0.09 1.00% |
Historical analysis of Anavex Life income statement accounts such as Other Operating Expenses of 67.3 M, Total Operating Expenses of 67.3 M or Gross Profit of 0.0 can show how well Anavex Life Sciences performed in making a profits. Evaluating Anavex Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Anavex Life's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Anavex Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anavex Life Sciences is a good buy for the upcoming year.
Anavex |
About Anavex Income Statement Analysis
Anavex Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Anavex Life shareholders. The income statement also shows Anavex investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Anavex Life Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anavex Life Sciences. It is also known as Anavex Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most accounts from Anavex Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, Anavex Life's Research Development is quite stable compared to the past year. Non Operating Income Net Other is expected to rise to about 2.9 M this year, although the value of EBIT is projected to rise to (40.6 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Tax Provision | 358.5K | 7K | 8.1K | 7.6K | Interest Income | 947.0K | 6.5M | 7.5M | 7.9M |
Anavex Life income statement Correlations
Click cells to compare fundamentals
Anavex Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anavex Life income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 4.8M | 4.0M | 947.0K | 964K | 1.1M | 1.3M | |
| Other Operating Expenses | 30.9M | 41.9M | 51.0M | 55.8M | 64.1M | 67.3M | |
| Operating Income | (30.8M) | (41.9M) | (54.4M) | (47.5M) | (42.7M) | (40.6M) | |
| Ebit | (57.8M) | (79.1M) | (47.6M) | (47.5M) | (42.7M) | (40.6M) | |
| Ebitda | (31.1M) | (41.7M) | (50.9M) | (47.5M) | (42.7M) | (40.6M) | |
| Total Operating Expenses | 30.9M | 41.9M | 51.0M | 55.8M | 64.1M | 67.3M | |
| Net Income | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.7M) | (40.6M) | |
| Income Tax Expense | 22.7K | 267.6K | 358.5K | (7K) | (6.3K) | (6.0K) | |
| Depreciation And Amortization | 26.7M | 37.5M | (3.3M) | (2.7K) | (3.1K) | (3.0K) | |
| Income Before Tax | (26.3M) | (37.6M) | (47.6M) | (47.5M) | (42.7M) | (40.6M) | |
| Total Other Income Expense Net | 4.8M | 4.4M | 3.4M | 2.7M | 3.1M | 3.2M | |
| Selling General Administrative | 5.9M | 9.0M | 13.1M | 12.0M | 13.8M | 14.5M | |
| Research Development | 25.2M | 33.0M | 37.9M | 43.7M | 50.3M | 52.8M | |
| Net Income From Continuing Ops | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.8M) | (40.6M) | |
| Non Operating Income Net Other | 2.7M | 4.7M | 4.3M | 2.4M | 2.8M | 2.9M | |
| Net Income Applicable To Common Shares | (26.3M) | (37.9M) | (48.0M) | (47.5M) | (42.8M) | (40.6M) | |
| Interest Income | 180.0K | 26.3K | 947.0K | 6.5M | 7.5M | 7.9M | |
| Tax Provision | 22.7K | 267.6K | 358.5K | 7K | 8.1K | 7.6K | |
| Net Interest Income | 180.0K | 26.3K | 947.0K | 5.6M | 6.4M | 6.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.